Tearsheet

Illumina (ILMN)

Market Price (9/13/2025): $95.36 | Market Cap: $15.0 Bil
Sector: Health Care | Industry: Life Sciences Tools & Services

Illumina (ILMN)

Market Price (9/13/2025): $95.36
Market Cap: $15.0 Bil
Sector: Health Care
Industry: Life Sciences Tools & Services

Investment Highlights

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 8.4%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.9%, FCF Yield is 6.9%	Weak multi-year price returns 2Y Excs Rtn is -86%, 3Y Excs Rtn is -118%	Weak revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -3.3%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.0%, Rev Chg QQuarterly Revenue Change % is -4.8%
1	Attractive operating margins Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 19%
2	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 27%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 24%
3	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -28%
4	Low stock price volatility Vol 12M is 42%

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 8.4%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.9%, FCF Yield is 6.9%
1	Attractive operating margins Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 19%
2	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 27%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 24%
3	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -28%
4	Low stock price volatility Vol 12M is 42%
5	Weak multi-year price returns 2Y Excs Rtn is -86%, 3Y Excs Rtn is -118%
6	Weak revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -3.3%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.0%, Rev Chg QQuarterly Revenue Change % is -4.8%

Market Valuation

	9/13/25	2024	2023	2022	2021
Share Price CYE	$95.36	$133.63	$135.32	$196.50	$369.72
Market Cap CYE ($ Bil)	15.0	21.2	21.4	30.9	56.2
Total Debt ($ Bil)	2.6	2.6	2.3	3.6	2.5
Total Cash ($ Bil)	1.2	1.2	1.1	2.0	1.3
Enterprise Value ($ Bil)	16.4	23.8	23.7	34.5	58.7
Valuation Ratios
P/S TTM	3.5	4.9	4.8	6.7	12.2
P/EBIT TTM	9.9	-19.7	-20.6	-7.2	58.7
P/E TTM	11.9	-17.4	-18.4	-7.0	72.8
Sector Ratios
P/S TTM (Sector)	3.8	3.6	4.1	4.5	7.3
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4	-1.3	-2.9
P/E TTM (Sector)	-1.9	-1.6	-1.5	-1.4	-2.9

	9/13/25	2024	2023
Share Price CYE	$95.36	$133.63	$135.32
Market Cap CYE ($ Bil)	15.0	21.2	21.4
Total Debt ($ Bil)	2.6	2.6	2.3
Total Cash ($ Bil)	1.2	1.2	1.1
Enterprise Value ($ Bil)	16.4	23.8	23.7
Valuation Ratios
P/S TTM	3.5	4.9	4.8
P/EBIT TTM	9.9	-19.7	-20.6
P/E TTM	11.9	-17.4	-18.4
Sector Ratios
P/S TTM (Sector)	3.8	3.6	4.1
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4
P/E TTM (Sector)	-1.9	-1.6	-1.5

Stock Price
Market Cap

Stock Price Chart

Return (1Y):

Market Cap Chart

Business Description

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Show more

Price Returns Compared

Expand for Detailed View

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
ILMN Return	12%	3%	-47%	-31%	-1%	-26%	-69%
Peers Return	44%	38%	-27%	10%	-20%	-16%	7%
S&P 500 Return	16%	27%	-19%	24%	23%	12%	101%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: TMO, A, BRKR, TXG, DHR. See ILMN Returns vs. Peers.
[3] 2025 data is for the year up to 9/12/2025 (YTD)

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	Illumina Earnings Notes
2	Illumina vs Johnson & Johnson: Which Is A Better Investment?	Counter-Intuitive Comparisons
3	Illumina vs IQVIA: Which Is A Better Investment?	Counter-Intuitive Comparisons
4	How Does ILMN Stack Up Against Its Peers?	Peer Comparison
5	Better Bet Than ILMN Stock: Pay Less Than Illumina To Get More From AA, PTCT
6	Better Bet Than ILMN Stock: Pay Less Than Illumina To Get More From PTCT
7	ILMN Dip Buy Analysis
8	Illumina Total Shareholder Return (TSR): 0.0% in 2024 and -28.5% 3-yr compounded annual returns (below peer average)
9	Illumina (ILMN) Operating Cash Flow Comparison	Financials
10	Illumina (ILMN) Net Income Comparison	Financials
11	ARTICLES
12	What’s Happening With Illumina Stock?		July 11th, 2024
13	Up Nearly 15% In A Week Will Illumina Stock Continue To See Higher Levels?		June 7th, 2024
14	Will Illumina Stock Rebound After A 65% Decline In The Ongoing Inflation Shock?		July 6th, 2023
15	Is Illumina Stock A Better Pick Over TMO?		May 24th, 2023
16	What’s Happening With Illumina Stock?		January 12th, 2023

	Title
0	DASHBOARDS
1	What’s Happening With Illumina Stock?
2	Up Nearly 15% In A Week Will Illumina Stock Continue To See Higher Levels?
3	Will Illumina Stock Rebound After A 65% Decline In The Ongoing Inflation Shock?
4	Is Illumina Stock A Better Pick Over TMO?
5	What’s Happening With Illumina Stock?
6	ARTICLES
7	Illumina Earnings Notes
8	Illumina vs Johnson & Johnson: Which Is A Better Investment?
9	Illumina vs IQVIA: Which Is A Better Investment?
10	How Does ILMN Stack Up Against Its Peers?
11	Better Bet Than ILMN Stock: Pay Less Than Illumina To Get More From AA, PTCT
12	Better Bet Than ILMN Stock: Pay Less Than Illumina To Get More From PTCT
13	ILMN Dip Buy Analysis
14	Illumina Total Shareholder Return (TSR): 0.0% in 2024 and -28.5% 3-yr compounded annual returns (below peer average)
15	Illumina (ILMN) Operating Cash Flow Comparison
16	Illumina (ILMN) Net Income Comparison

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GCTK	GlucoTrack	117.5%	-97.6%
2	OPI	Office Properties Income Trust	78.6%	-42.6%
3	HCWB	HCW Biologics	68.4%	-68.7%
4	AGAE	Allied Gaming & Entertainment	62.4%	86.8%
5	ATCH	AtlasClear	53.4%	-95.9%
6	SONN	Sonnet BioTherapeutics	49.0%	304.1%
7	EVTV	Envirotech Vehicles	48.4%	-66.3%
8	ISPC	iSpecimen	47.7%	-26.6%
9	ENTO	Entero Therapeutics	37.0%	68.8%
10	IBEX	IBEX	36.5%	93.5%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	NXTT	Next Technology	-57.4%	-93.8%
2	VCIG	VCI Global	-42.8%	-98.7%
3	RENT	Rent the Runway	-36.4%	-40.9%
4	NUAI	New Era Energy & Digital	-30.5%
5	AEI	Alset	-29.6%	156.9%
6	NAKA	Kindly MD	-29.5%
7	XTIA	XTI Aerospace	-24.6%	-85.8%
8	FARM	Farmer Bros	-21.5%	1.7%
9	FEIM	Frequency Electronics	-21.0%	46.5%
10	MSS	Maison Solutions	-20.4%	-27.6%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	OCTO	Eightco	900.0%	562.1%
2	QMMM	QMMM	875.3%	5698.4%
3	WLDS	Wearable Devices	780.4%	8.0%
4	CWD	CaliberCos	268.8%	-45.1%
5	AIRE	ReAlpha Tech	257.5%	-49.8%
6	PTNM	Pitanium	154.0%
7	OPI	Office Properties Income Trust	144.0%	-42.6%
8	HYPD	Hyperion DeFi	144.0%
9	ISPC	iSpecimen	128.4%	-26.6%
10	EDHL	Everbright Digital	127.6%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	DGNX	Diginex	-85.6%
2	LGCL	Lucas GC	-69.1%	-76.6%
3	YYGH	YY	-68.7%	-76.6%
4	BINI	Bollinger Innovations	-61.6%	-100.0%
5	IPDN	Professional Diversity Network	-54.5%	-41.4%
6	INHD	Inno	-53.4%	-4.4%
7	CDT	CDT Equity	-49.2%	-99.4%
8	NFE	New Fortress Energy	-46.5%	-91.3%
9	TGHL	Growhub	-44.8%
10	SLXN	Silexion Therapeutics	-43.1%	-86.5%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	11249.2%	11249.2%
2	GIBO	GIBO	7400.0%
3	LNZA	LanzaTech Global	4710.5%	-85.8%
4	CHSN	Chanson International	3717.0%	-99.3%
5	QMMM	QMMM	2669.4%	5698.4%
6	VTAK	Catheter Precision	1332.7%	-71.4%
7	CURX	Curanex Pharmaceuticals	1309.0%	1309.0%
8	OCTO	Eightco	811.9%	562.1%
9	WLDS	Wearable Devices	708.6%	8.0%
10	PTNM	Pitanium	423.7%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	BINI	Bollinger Innovations	-93.4%	-100.0%
2	ETS	Elite Express	-92.8%	-92.8%
3	CJET	Chijet Motor	-92.7%	-94.6%
4	ELPW	Elong Power	-91.7%	-75.8%
5	STFS	Star Fashion Culture	-91.4%	-97.8%
6	JEM	707 Cayman	-90.4%	-98.0%
7	FLYE	Fly-E	-90.4%	-82.8%
8	NXTT	Next Technology	-89.3%	-93.8%
9	NUTR	NusaTrip	-87.2%	-87.2%
10	CUPR	Cuprina	-84.3%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GCTK	GlucoTrack	117.5%	-97.6%
2	OPI	Office Properties Income Trust	78.6%	-42.6%
3	HCWB	HCW Biologics	68.4%	-68.7%
4	AGAE	Allied Gaming & Entertainment	62.4%	86.8%
5	ATCH	AtlasClear	53.4%	-95.9%
6	SONN	Sonnet BioTherapeutics	49.0%	304.1%
7	EVTV	Envirotech Vehicles	48.4%	-66.3%
8	ISPC	iSpecimen	47.7%	-26.6%
9	ENTO	Entero Therapeutics	37.0%	68.8%
10	IBEX	IBEX	36.5%	93.5%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	NXTT	Next Technology	-57.4%	-93.8%
2	VCIG	VCI Global	-42.8%	-98.7%
3	RENT	Rent the Runway	-36.4%	-40.9%
4	NUAI	New Era Energy & Digital	-30.5%
5	AEI	Alset	-29.6%	156.9%
6	NAKA	Kindly MD	-29.5%
7	XTIA	XTI Aerospace	-24.6%	-85.8%
8	FARM	Farmer Bros	-21.5%	1.7%
9	FEIM	Frequency Electronics	-21.0%	46.5%
10	MSS	Maison Solutions	-20.4%	-27.6%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	OCTO	Eightco	900.0%	562.1%
2	QMMM	QMMM	875.3%	5698.4%
3	WLDS	Wearable Devices	780.4%	8.0%
4	CWD	CaliberCos	268.8%	-45.1%
5	AIRE	ReAlpha Tech	257.5%	-49.8%
6	PTNM	Pitanium	154.0%
7	OPI	Office Properties Income Trust	144.0%	-42.6%
8	HYPD	Hyperion DeFi	144.0%
9	ISPC	iSpecimen	128.4%	-26.6%
10	EDHL	Everbright Digital	127.6%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	DGNX	Diginex	-85.6%
2	LGCL	Lucas GC	-69.1%	-76.6%
3	YYGH	YY	-68.7%	-76.6%
4	BINI	Bollinger Innovations	-61.6%	-100.0%
5	IPDN	Professional Diversity Network	-54.5%	-41.4%
6	INHD	Inno	-53.4%	-4.4%
7	CDT	CDT Equity	-49.2%	-99.4%
8	NFE	New Fortress Energy	-46.5%	-91.3%
9	TGHL	Growhub	-44.8%
10	SLXN	Silexion Therapeutics	-43.1%	-86.5%

Peer Comparisons for Illumina

Financials

	ILMN	TMO	A	BRKR	TXG	DHR	Median
Name	Illumina	Thermo F.	Agilent .	Bruker	10x Geno.	Danaher
Mkt Price	95.12	479.46	123.24	30.91	12.64	190.05	109.18
Mkt Cap	14.9	181.2	35.0	4.7	1.6	136.2	25.0
Rev LTM	4,284	43,211	6,788	3,443	644	24,013	5,536
Op Inc LTM	824	7,860	1,444	329	-150	4,417	1,134
FCF LTM	1,024	6,170	1,088	49	57	4,862	1,056
FCF 3Y Avg	386	6,662	1,308	139	-32	5,733	847
CFO LTM	1,154	7,578	1,495	166	67	6,169	1,324
CFO 3Y Avg	628	8,206	1,662	260	16	7,013	1,145

Growth & Margins

	ILMN	TMO	A	BRKR	TXG	DHR	Median
Name	Illumina	Thermo F.	Agilent .	Bruker	10x Geno.	Danaher
Rev Chg LTM	-3.3%	2.0%	4.5%	10.4%	2.0%	1.9%	2.0%
Rev Chg 3Y Avg	-3.0%	0.3%	0.8%	11.6%	9.1%	-2.6%	0.6%
Rev Chg Q	-4.8%	3.0%	10.1%	-0.4%	12.9%	3.4%	3.2%
QoQ Delta Rev Chg LTM	-1.2%	0.7%	2.4%	-0.1%	3.2%	0.8%	0.8%
Op Mgn LTM	19.2%	18.2%	21.3%	9.5%	-23.3%	18.4%	18.3%
Op Mgn 3Y Avg	6.7%	17.4%	21.5%	13.7%	-28.4%	21.6%	15.5%
QoQ Delta Op Mgn LTM	-0.6%	-0.1%	-0.1%	-1.3%	5.7%	-1.9%	-0.3%
CFO/Rev LTM	26.9%	17.5%	22.0%	4.8%	10.4%	25.7%	19.8%
CFO/Rev 3Y Avg	14.5%	19.1%	24.6%	8.7%	2.4%	29.9%	16.8%
FCF/Rev LTM	23.9%	14.3%	16.0%	1.4%	8.8%	20.2%	15.2%
FCF/Rev 3Y Avg	9.0%	15.5%	19.4%	4.7%	-5.8%	24.4%	12.2%

Valuation

	ILMN	TMO	A	BRKR	TXG	DHR	Median
Name	Illumina	Thermo F.	Agilent .	Bruker	10x Geno.	Danaher
Mkt Cap	14.9	181.2	35.0	4.7	1.6	136.2	25.0
P/S	3.5	4.2	5.2	1.4	2.4	5.7	3.8
P/EBIT	9.9	21.6	23.2	24.3	-19.7	31.2	22.4
P/E	11.9	27.5	28.7	58.9	-18.5	39.9	28.1
P/CFO	12.9	23.9	23.4	28.2	23.4	22.1	23.4
Total Yield	8.4%	3.6%	4.3%	2.3%	-5.4%	2.5%	3.1%
Dividend Yield	0.0%	0.0%	0.8%	0.7%	0.0%	0.0%	0.0%
FCF Yield 3Y Avg	2.7%	3.6%	3.7%	1.5%	0.2%	3.4%	3.1%
D/E	0.2	0.2	0.1	0.5	0.1	0.1	0.2
Net D/E	0.1	0.2	0.1	0.5	-0.2	0.1	0.1

Returns

	ILMN	TMO	A	BRKR	TXG	DHR	Median
Name	Illumina	Thermo F.	Agilent .	Bruker	10x Geno.	Danaher
1M Rtn	-5.9%	-1.1%	2.5%	-10.5%	-6.9%	-9.1%	-6.4%
3M Rtn	9.4%	19.0%	5.5%	-19.3%	21.4%	-5.1%	7.5%
6M Rtn	11.1%	-8.1%	2.1%	-32.6%	22.2%	-9.5%	-3.0%
12M Rtn	-24.7%	-21.7%	-8.9%	-52.1%	-43.9%	-29.9%	-27.3%
3Y Rtn	-50.8%	-13.6%	-5.7%	-43.7%	-61.7%	-23.0%	-33.3%
1M Excs Rtn	-7.7%	-2.9%	0.6%	-12.3%	-8.7%	-10.9%	-8.2%
3M Excs Rtn	-1.0%	6.5%	-5.1%	-31.4%	10.6%	-16.1%	-3.0%
6M Excs Rtn	-6.1%	-24.9%	-13.8%	-50.3%	8.7%	-25.8%	-19.3%
12M Excs Rtn	-43.2%	-42.8%	-29.8%	-70.8%	-61.5%	-50.3%	-46.7%
3Y Excs Rtn	-117.9%	-77.8%	-69.6%	-110.0%	-126.4%	-87.3%	-98.6%

Comparison Analyses

	Title
0	How Does ILMN Stack Up Against Its Peers?
1	Illumina vs. Thermo Fisher Scientific: With Return Forecast Of 31%, Thermo Fisher Scientific Is A Better Bet
2	With 19% Gains On The Table, PACB May Outshine ILMN
3	Illumina vs. Agilent Technologies: With Return Forecast Of 12%, Agilent Technologies Is A Better Bet
4	Illumina vs. Bruker: With Return Forecast Of 6.2%, Bruker Is A Better Bet
5	Illumina vs. Monster Beverage: With Return Forecast Of 54%, Illumina Is A Better Bet
6	Illumina vs. Edwards Lifesciences: With Return Forecast Of 54%, Illumina Is A Better Bet
7	Illumina vs. Intuitive Surgical: With Return Forecast Of 54%-55%, Both Seem Like Good Bets
8	Illumina vs. Xilinx: Similar Revenue, But Illumina Is A Better Bet
9	Illumina vs. Autodesk: Similar Revenue, Similar Bets

Financials

Annual
Quarterly

$ Mil \| FY: 12/29	LTM	2024	2023	2022	2021	2020	2019
Period End		12/29/2024	12/31/2023	1/1/2023	1/2/2022	1/3/2021	12/29/2019
Filing Date		2/12/2025	2/16/2024	2/17/2023	2/18/2022	2/17/2021	2/11/2020
Key Financials
Total Revenue	4,284	4,372	4,504	4,584	4,526	3,239	3,543
Ebitda	1,784	-725	-608	-3,916	1,196	1,092	1,358
Operating Income	824	600	-222	354	-123	580	985
Net Income	1,258	-1,223	-1,161	-4,404	762	656	1,002
EPS	7.92	-7.69	-7.34	-28.00	5.07	4.48	6.81
Growth Rates
Total Revenue Growth	-3.3%	-2.9%	-1.7%	1.3%	39.7%	-8.6%	6.3%
EBITDA Growth	170.5%	-19.2%	84.5%	-427.4%	9.5%	-19.6%	20.2%
Operating Income Growth	1484.6%	370.3%	-162.7%	387.8%	-121.2%	-41.1%	11.6%
Net Income Growth	141.3%	-5.3%	73.6%	-678.0%	16.2%	-34.5%	21.3%
Margins
EBITDA Margin	41.6%	-16.6%	-13.5%	-85.4%	26.4%	33.7%	38.3%
Operating Income Margin	19.2%	13.7%	-4.9%	7.7%	-2.7%	17.9%	27.8%
Net Income Margin	29.4%	-28.0%	-25.8%	-96.1%	16.8%	20.3%	28.3%
Cash & Debt
Total Cash	1,155	1,220	1,054	2,037	1,339	3,472	3,414
Total Debt	2,598	2,622	2,262	3,555	2,540	1,906	1,881
Net Debt / (Cash)	1,443	1,402	1,208	1,518	1,201	-1,566	-1,533
Cash Flows
Net Cash from Operations	1,154	837	478	392	545	1,080	1,051
Free Cash from Operations	1,024	709	283	106	337	891	842
Returns to Shareholders
Dividends	0	-0	-0	-0	-0	-0	-0
Share Repurchases	686	116	-0	-0	-0	736	324

$ Mil \| FY: 12/29	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3
Period End	6/29/2025	3/30/2025	12/29/2024	9/29/2024	6/30/2024	3/31/2024	12/31/2023	10/1/2023	7/2/2023	4/2/2023	1/1/2023	10/2/2022
Filing Date	8/1/2025	5/9/2025	2/12/2025	11/6/2024	8/7/2024	5/3/2024	2/16/2024	11/13/2023	8/10/2023	5/5/2023	2/17/2023	11/4/2022
Key Financials Quarterly
Total Revenue	1,059	1,041	1,104	1,080	1,112	1,076	1,122	1,119	1,176	1,087	1,083	1,115
Ebitda	399	276	283	826	-1,851	17	-40	-655	38	49	-53	-3,563
Operating Income	214	164	193	253	249	-111	-152	66	-88	-64	-106	246
Net Income	235	131	187	705	-1,988	-126	-175	-754	-234	3	-139	-3,816
EPS	1.49	0.83	1.17	4.43	-12.48	-0.79	-1.11	-4.77	-1.48	0.02	-0.89	-24.26
Key Financials TTM
Total Revenue TTM	4,284	4,337	4,372	4,390	4,429	4,493	4,504	4,465	4,461	4,447	4,583	4,699
Ebitda TTM	1,784	-466	-725	-1,048	-2,529	-640	-608	-621	-3,529	-4,104	-3,916	-3,675
Operating Income TTM	824	859	584	239	52	-285	-238	-192	-12	106	354	501
Net Income TTM	1,258	-965	-1,222	-1,584	-3,043	-1,289	-1,160	-1,124	-4,186	-4,487	-4,404	-4,153
Growth Rates Quarterly
Total Revenue Growth	-4.8%	-3.3%	-1.6%	-3.5%	-5.4%	-1.0%	3.6%	0.4%	1.2%	-11.1%	-9.7%	0.6%
EBITDA Growth	121.6%	1523.5%	807.5%	226.1%	-4971.1%	-65.3%	24.5%	81.6%	107.1%	-79.3%	-128.2%	-814.0%
Operating Income Growth	-14.1%	247.7%	227.0%	283.3%	383.0%	-73.4%	-43.4%	-73.2%	-393.3%	-134.8%	-358.5%	145.1%
Net Income Growth	111.8%	204.0%	206.9%	193.5%	-749.6%	-4300.0%	-25.9%	80.2%	56.3%	-96.5%	-224.1%	-1303.8%
Margins Quarterly
EBITDA Margin	37.7%	26.5%	25.6%	76.5%	-166.5%	1.6%	-3.6%	-58.5%	3.2%	4.5%	-4.9%	-319.6%
Operating Income Margin	20.2%	15.8%	17.5%	23.4%	22.4%	-10.3%	-13.5%	5.9%	-7.5%	-5.9%	-9.8%	22.1%
Net Income Margin	22.2%	12.6%	16.9%	65.3%	-178.8%	-11.7%	-15.6%	-67.4%	-19.9%	0.3%	-12.8%	-342.2%
Cash & Debt
Total Cash	1,155	1,237	1,220	939	994	1,108	1,054	933	1,559	1,518	2,037	1,041
Total Debt	2,598	2,607	2,622	2,674	2,921	2,276	2,262	2,272	3,048	3,062	3,555	2,566
Net Debt / (Cash)	1,443	1,370	1,402	1,735	1,927	1,168	1,208	1,339	1,489	1,544	1,518	1,525
Cash Flows Quarterly
FCF from Operations	234	240	364	316	80	77	224	139	105	10	147	-52
Cash Flows TTM
FCF from Operations TTM	1,154	1,000	837	697	520	545	478	401	210	230	392	527
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	370	200	17	99	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	45.6%	34.5%	55.1%	57.1%	51.7%	-13.6%	-19.1%	7.7%	-10.5%	-7.7%	-10.9%	30.2%
Return on Invested Capital (ROIC) TTM
ROIC TTM	51.5%	62.7%	41.7%	13.8%	2.7%	-8.8%	-7.5%	-5.8%	-0.4%	3.1%	11.0%	15.4%

Segment Financials

Revenue by Segment

$ Mil	2024	2023	2022	2021	2020
Core Illumina	4,438	4,553	4,519	3,239	3,543
GRAIL	93	55	12
Eliminations	-26	-24	-5		-1
Helix					1
Total	4,505	4,584	4,526	3,239	3,543

Operating Income by Segment

$ Mil	2024	2023	2022	2021	2020
Core Illumina	552	481	808	580	1,008
Eliminations			0		-24
GRAIL			-931
Helix					1
Total	552	481	-123	580	985

Assets by Segment

$ Mil	2024	2023	2022	2021	2020
Core Illumina				7,585	7,316
Total				7,585	7,316

Price Behavior

Behavior Stats
Betas Matrix

Price Behavior

Market Price	$95.12
Market Cap ($ Bil)	14.9
First Trading Date	07/28/2000
Distance from 52W High	-38.7%
	50 Days	200 Days
DMA Price	$99.47	$101.96
DMA Trend	down	up
Distance from DMA	-4.4%	-6.7%
	3M	1YR
Volatility	38.3%	42.2%
Downside Capture	216.47	152.82
Upside Capture	153.78	98.54
Correlation (SPY)	48.4%	50.3%

ILMN Betas & Captures as of 8/31/2025

	1M	2M	3M	6M	1Y	3Y
Beta	2.14	2.20	1.80	1.08	1.07	1.23
Up Beta	2.13	0.97	0.61	0.89	0.85	1.20
Down Beta	5.01	4.47	3.79	1.01	1.14	1.24
Up Capture	99%	186%	203%	157%	99%	96%
Bmk +ve Days	10	22	35	71	142	415
Stock +ve Days	11	20	36	63	120	354
Down Capture	190%	253%	155%	126%	125%	106%
Bmk -ve Days	11	19	27	54	106	334
Stock -ve Days	10	21	26	62	128	395

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	8292025
Short Interest: Shares Quantity	7,215,892
Short Interest: % Change Since 8152025	-4.0%
Average Daily Volume	1,356,672
Days-to-Cover Short Interest	5.32
Basic Shares Quantity	157,000,000
Short % of Basic Shares	4.6%

Returns Analyses

	Title
0	Will You Be Comfortable Buying Illumina Stock?
1	Illumina Stock Return Comparison

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
7/31/2025	-7.8%	-7.0%	-2.7%
5/8/2025	-4.8%	1.7%	6.8%
1/14/2025	-5.4%	-2.0%	-28.2%
11/4/2024	1.0%	-1.3%	-7.2%
8/6/2024	4.1%	2.9%	11.5%
5/2/2024	-4.9%	-10.2%	-16.6%
2/8/2024	-3.8%	1.9%	-3.0%
11/9/2023	-8.0%	-11.0%	10.0%
...
SUMMARY STATS
# Positive	6	7	8
# Negative	18	17	16
Median Positive	2.5%	3.8%	7.7%
Median Negative	-6.2%	-8.1%	-8.7%
Max Positive	7.9%	13.3%	24.9%
Max Negative	-14.6%	-25.5%	-28.2%

	Forward Returns
7/31/2025	-7.8%	-7.0%	-2.7%
5/8/2025	-4.8%	1.7%	6.8%
1/14/2025	-5.4%	-2.0%	-28.2%
11/4/2024	1.0%	-1.3%	-7.2%
8/6/2024	4.1%	2.9%	11.5%
5/2/2024	-4.9%	-10.2%	-16.6%
2/8/2024	-3.8%	1.9%	-3.0%
11/9/2023	-8.0%	-11.0%	10.0%
8/9/2023	0.3%	-8.1%	-14.2%
4/25/2023	-3.5%	-10.8%	-2.8%
2/7/2023	-8.0%	-1.3%	-6.1%
11/3/2022	5.9%	13.3%	0.9%
8/11/2022	-8.4%	-8.1%	-6.6%
5/5/2022	-14.6%	-25.5%	-22.3%
2/10/2022	-7.6%	-11.2%	-14.5%
11/4/2021	-3.2%	-8.7%	-16.6%
8/5/2021	-3.6%	-1.0%	-9.4%
4/5/2021	7.9%	3.8%	-1.6%
1/12/2021	0.2%	11.7%	24.9%
10/29/2020	-7.0%	-1.0%	2.3%
8/6/2020	-10.9%	-11.5%	-14.3%
4/14/2020	-1.2%	4.2%	8.6%
1/16/2020	-0.4%	-2.0%	-8.0%
10/24/2019	-7.9%	-6.3%	0.0%
SUMMARY STATS
# Positive	6	7	8
# Negative	18	17	16
Median Positive	2.5%	3.8%	7.7%
Median Negative	-6.2%	-8.1%	-8.7%
Max Positive	7.9%	13.3%	24.9%
Max Negative	-14.6%	-25.5%	-28.2%

SEC Filings

Expand for More

Report Date	Filing
6302025	10-Q 6/29/2025
3312025	10-Q 3/30/2025
12312024	10-K 12/29/2024
9302024	10-Q 9/29/2024
6302024	10-Q 6/30/2024
3312024	10-Q 3/31/2024
12312023	10-K 12/31/2023
9302023	10-Q 10/1/2023
6302023	10-Q 7/2/2023
3312023	10-Q 4/2/2023
12312022	10-K 1/1/2023
9302022	10-Q 10/2/2022
6302022	10-Q 7/3/2022
3312022	10-Q 4/3/2022
12312021	10-K 1/2/2022
9302021	10-Q 10/3/2021

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Dhingra Ankur	SVP, Chief Financial Officer	5142025	Buy	81.21	6,100	495,381	2,022,616	Form
1	Thaysen Jacob	Chief Executive Officer	5142025	Buy	79.70	1,200	95,640	5,757,528	Form

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Illumina (ILMN)

Market Price (9/13/2025): $95.36 | Market Cap: $15.0 BilSector: Health Care | Industry: Life Sciences Tools & Services

Illumina (ILMN)

Market Price (9/13/2025): $95.36Market Cap: $15.0 BilSector: Health CareIndustry: Life Sciences Tools & Services

Investment Highlights

Market Valuation

Stock Price Chart

Market Cap Chart

Business Description

Price Returns Compared

Interactive Breakdown

Better Bets than Illumina (ILMN)

Latest Trefis Analyses

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Illumina

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (9/13/2025): $95.36 | Market Cap: $15.0 Bil
Sector: Health Care | Industry: Life Sciences Tools & Services

Market Price (9/13/2025): $95.36
Market Cap: $15.0 Bil
Sector: Health Care
Industry: Life Sciences Tools & Services